首页> 外文期刊>Open Access Library Journal >&i&Escherichia coli&/i& Resistance to Ciprofloxacin in Acute Uncomplicated Pyelonephritis
【24h】

&i&Escherichia coli&/i& Resistance to Ciprofloxacin in Acute Uncomplicated Pyelonephritis

机译:大肠杆菌/ i。急性并发性肾盂肾炎对环丙沙星的耐药性

获取原文
       

摘要

Background: Severe acute uncomplicated pyelonephritis is an infection of the kidneys that usually have an ascending route and occur in presumably healthy urinary tract. The most common pathogen involved is E. coli . The Infectious Diseases Society of America (IDSA) has issued an updated guideline in 2010 suggesting IV quinolones to be considered in the initial empiric antimicrobial therapy giving known resistanc e of less than 10%. However, E. coli resistance to quinolones has been increasing, the recent data of E. coli , causing pyelonephritis, resistance is not known in the Midwest. Local hospital antibiogram for two years showed up to 22% resistance to ciprofloxacin among E. coli isolates. Methods: We conduct a retrospective non-concurrent cohort study in one teaching hospital in the Midwest, females who were admitted with severe acute uncomplicated pyelonephritis in a three years period were included. Patients with urinary tract obstruction, pregnancy, immuno-suppression, males, and indwelling Foley’s catheters were excluded. Data collected include causative pathogens and resistance to antibiotics were collected. Percentages, frequencies, and measures of central tendency and dispersion were calculated to describe the study sample Results: 73 patients were included in the final analysis. E. coli was the most common isolated pathogen (81%), followed by other enteric gram negative. E. coli resistance to ciprofloxacin was 13.5%, 37% to trimethoprim-sulfamethoxazole, and 5% to ceftriaxone. Conclusion: Ciprofloxacin should be avoided initially in treating severe acute uncomplicated pyelonephritis until culture results and sensitivity is available.
机译:背景:严重的急性并发性肾盂肾炎是肾脏的一种感染,通常具有上升的途径,并可能在健康的泌尿道中发生。涉及的最常见病原体是大肠杆菌。美国传染病学会(IDSA)在2010年发布了更新指南,建议在经验性抗微生物药物的初始耐药性低于10%的初始经验性抗菌治疗中考虑使用IV喹诺酮类药物。但是,大肠杆菌对喹诺酮类药物的耐药性一直在增加,最近的大肠杆菌数据显示,引起肾盂肾炎的耐药性在中西部尚不知道。两年来当地医院的抗菌素谱图显示,大肠杆菌分离株对环丙沙星的耐药率高达22%。方法:我们在中西部的一家教学医院进行了一项回顾性非同期队列研究,其中包括在三年内被收治的严重急性并发性肾盂肾炎的女性。排除了患有尿路阻塞,妊娠,免疫抑制,男性和留有Foley导管的患者。收集的数据包括病原体,并收集了对抗生素的耐药性。计算百分比,频率以及中心趋势和离散度的量度以描述研究样本。结果:73名患者被纳入最终分析。大肠杆菌是最常见的分离病原体(81%),其次是其他肠道革兰氏阴性。大肠杆菌对环丙沙星的耐药性为13.5%,对甲氧苄啶-磺胺甲基异恶唑的耐药率为37%,对头孢曲松的耐药率为5%。结论:开始治疗严重的急性并发性肾盂肾炎时应避免使用环丙沙星,直到获得培养结果和敏感性为止。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号